Abstract:The human pathogenic bacterium Helicobacter pylori has been ascertained to be an aetiological agent for chronic active gastritis and a significant determinant in peptic and duodenal ulcer diseases. Endophytic metabolites are being recognized as a versatile arsenal of antimicrobial agents, since some endophytes have been shown to possess superior biosynthetic capabilities owing to their presumable gene recombination with the host, while residing and reproducing inside the healthy plant tissues. A total of 32 endophytic fungi isolated from the medicinal herb Cynodon dactylon (Poaceae) were grown in in vitro culture, and the ethyl acetate extracts of the cultures were examined in vitro for the anti- H. pylori activity. As a result, a total of 16 endophyte culture extracts were identified as having potent anti- H. pylori activities. Subsequently, a detailed bioassay-guided fractionation of the extract of the most active endophyte (strain number: CY725) identified as Aspergillus sp., was performed to afford eventually four anti- H. pylori secondary metabolites. The four isolated compounds were identified through a combination of spectral and chemical methods (IR, MS, 1 H- and 13 C-NMR) to be helvolic acid, monomethylsulochrin, ergosterol and 3 β -hydroxy-5 α ,8 α -epidioxy- ergosta-6,22-diene with corresponding MICs of 8.0, 10.0, 20.0 and 30.0 μ g/ml, respectively. The MIC of ampicillin co-assayed as a reference drug against H. pylori was 2.0 μ g/ml. Furthermore, preliminary examination of the antimicrobial spectrum of helvolic acid, the most active anti- H. pylori metabolite characterized from the endophyte culture, showed that it was inhibitory to the growth of Sarcina lutea , Staphylococcus aureus and Candida albicans with MICs of 15.0, 20.0 and 30.0 μ g/ml, respectively.

Anti-Helicobacter Pylori Metabolites from Rhizoctonia Sp. Cy064, an Endophytic Fungus in Cynodon Dactylon

Chemical Investigation of a Co-Culture of Aspergillus Fumigatus D and Fusarium Oxysporum R1

Cytosporins A-D, Novel Benzophenone Derivatives from the Endophytic Fungus Cytospora Rhizophorae A761

Benzopyran Derivatives and an Aliphatic Compound from a Mangrove Endophytic Fungus Penicillium citrinum QJF‐22

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Three New Polyketides from the Insect-Associated Fungus Letendraea Sp. 5XNZ4-2

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

Polyketides from Neohelicosporium griseum: structure assignment and bioactivity investigation

Anti‐inflammatory Polyketides from an Endophytic Fungus Chaetomium sp. UJN‐EF006 of Vaccinium bracteatum

Antifungal Metabolite With A New Carbon Skeleton From Keissleriella Sp Y54108, A Marine Filamentous Fungus

Metabolites from the endophytic mitosporic Dothideomycete sp. LRUB20

Two New Compounds from the Endophytic Fungi of Dryopteris crassirhizoma and Their Antimicrobial Activities

A New Antibacterial 3,5-Dimethylorsellinic Acid-Based Meroterpene from the Marine Fungus Aspergillus Sp. CSYZ-1.

Rhizophols A and B, Antioxidant and Axially Chiral Benzophenones from the Endophytic Fungus Cytospora Rhizophorae.

Anti- Helicobacter pylori substances from endophytic fungal cultures

A new tetrahydroxybenzophenone from a marine-associated fungus of penicillium sp. and its potential antibacterial activity

A new sesquiterpene from endophytic fungus Colletotrichum sp. B-89

Chaetoglocins A-D, four new metabolites from the endophytic fungus Chaetomium globosum

Two New Anisic Acid Derivatives from Endophytic Fungus Rhizopycnis vagum Nitaf22 and Their Antibacterial Activity

Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51